Gibson Christopher's Form 4 filing
Recursion Pharmaceuticals, Inc. (RXRX) · filed Nov 15, 2024
- Accession no.
- 0001601830-24-000207
- Filed
- Nov 15, 2024
- Trade date
- Nov 13-14, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $301.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gibson ChristopherCIK 0001856369 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | CConversionAcquired | +20,000 | $0.00 | $0 | 782,656 | Direct | |
| Nov 13, 2024 | Class A Common Stock | SSaleDisposed | −20,000 | $7.74 | −$154,800 | 762,656 | Direct | |
| Nov 14, 2024 | Class A Common Stock | CConversionAcquired | +20,000 | $0.00 | $0 | 782,656 | Direct | |
| Nov 14, 2024 | Class A Common Stock | SSaleDisposed | −20,000 | $7.35 | −$147,000 | 762,656 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2024 | Class A Common Stock | CConversionDisposed | −20,000 | $0.00 | $0 | 6,076,700 | Direct | |
| Nov 14, 2024 | Class A Common Stock | CConversionDisposed | −20,000 | $0.00 | $0 | 6,056,700 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.